KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Accumulated Expenses (2016 - 2025)

Zimmer Biomet Holdings has reported Accumulated Expenses over the past 16 years, most recently at $834.5 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $834.5 million for Q4 2025, up 18.12% from a year ago — trailing twelve months through Dec 2025 was $834.5 million (up 18.12% YoY), and the annual figure for FY2025 was $834.5 million, up 18.12%.
  • Accumulated Expenses for Q4 2025 was $834.5 million at Zimmer Biomet Holdings, up from $706.5 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for ZBH hit a ceiling of $834.5 million in Q4 2025 and a floor of $184.5 million in Q1 2022.
  • Median Accumulated Expenses over the past 5 years was $317.6 million (2021), compared with a mean of $416.1 million.
  • Biggest five-year swings in Accumulated Expenses: plummeted 63.62% in 2021 and later surged 83.34% in 2022.
  • Zimmer Biomet Holdings' Accumulated Expenses stood at $317.6 million in 2021, then soared by 83.34% to $582.3 million in 2022, then fell by 28.37% to $417.1 million in 2023, then soared by 69.38% to $706.5 million in 2024, then rose by 18.12% to $834.5 million in 2025.
  • The last three reported values for Accumulated Expenses were $834.5 million (Q4 2025), $706.5 million (Q4 2024), and $417.1 million (Q4 2023) per Business Quant data.